Cancer care startup Oncare has raised ₹27 crore (approximately $4 million) in a Series A funding round led by Sky Impact Capital.
The round also saw participation from Huddle Ventures, Lotus Herbal Group, SteerX, and Tremis Capital.
The Gurugram-based startup had earlier raised $1 million in a seed funding round led by Huddle Ventures.
The fresh capital will be deployed to expand operations into new metro markets as well as tier-II and tier-III cities, while also strengthening its technology infrastructure to streamline clinical workflows, improve care coordination, and enhance patient experience.
Founded in 2023 by Amar Sneh and Deepak Kumar, Oncare runs a distributed oncology care platform aimed at making cancer treatment more affordable and standardised. Rather than investing in large standalone hospitals, the company collaborates with mid-sized accredited hospitals to establish and operate dedicated oncology centres through a capital-light approach.
Oncare integrates medical, surgical, and radiation oncology services within partner hospitals, offering comprehensive cancer care that includes chemotherapy, surgeries, immunotherapy, radiation therapy, and continuous nursing and nutritional support. The company claims its model helps reduce treatment costs by 30–40% compared to large corporate hospitals.
Currently, Oncare operates four oncology centres across Delhi-NCR and has built a multi-centre platform within three years of launch. With the new funding, the startup is targeting nationwide expansion, including entry into southern India and select tertiary markets.
